Showing results (1-10 of 212) with videos related to
Sort By:
Pageof 22
Advances in Virus Research|August 24, 2019
Entry of betaherpesvirusesMitsuhiro Nishimura, Yasuko MoriAdvances in Experimental Medicine and Biology|June 14, 2018
Structural Aspects of Betaherpesvirus-Encoded ProteinsMitsuhiro Nishimura, Yasuko MoriThe Kobe Journal of Medical Sciences|May 12, 2017
Purification, Crystallization and X-ray Diffraction Study of the C-terminal Domain of Human Herpesvirus 6A Immediate Early Protein 2Junjie Wang, Mitsuhiro Nishimura, Aika Wakata, et al.The Kobe Journal of Medical Sciences|April 27, 2025
Primary Infection with Early SARS-CoV-2 (D614G) Induces Cross Neutralization Antibodies against Omicron BA.5 and EG.5.1Maria Istiqomah Marini, Rei Takamiya, Mitsuhiro Nishimura, et al.Journal of Virology|August 11, 2017
Crystal Structure of the DNA-Binding Domain of Human Herpesvirus 6A Immediate Early Protein 2Mitsuhiro Nishimura, Junjie Wang, Aika Wakata, et al.Journal of Virology|September 22, 2021
Human Herpesvirus 6A Tegument Protein U14 Induces NF-κB Signaling by Interacting with p65Salma Aktar, Jun Arii, Lidya Handayani Tjan, et al.Journal of Virology|September 6, 2023
Human herpesvirus 6A nuclear matrix protein U37 interacts with heat shock transcription factor 1 and activates the heat shock responseJing Rin Huang, Jun Arii, Mansaku Hirai, et al.Journal of Virology|March 8, 2019
Humanization of Murine Neutralizing Antibodies against Human Herpesvirus 6BBochao Wang, Mitsuhiro Nishimura, Yuji Maekawa, et al.Microbiology and Immunology|August 23, 2020
Human herpesvirus 6A U27 plays an essential role for the virus propagationAnna Lystia Poetranto, Aika Wakata, Lidya Handayani Tjan, et al.JAMA Network Open|May 9, 2022
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 VaccineKoichi Furukawa, Lidya Handayani Tjan, Yukiya Kurahashi, et al.Pageof 22